| Autor: |
Harrison WO; Department of Medicine, University of California, San Diego, School of Medicine. |
| Jazyk: |
angličtina |
| Zdroj: |
Hospital practice (Office ed.) [Hosp Pract (Off Ed)] 1991 Sep; Vol. 26 Suppl 5, pp. 20-3; discussion 55. |
| DOI: |
10.1080/21548331.1991.11707739 |
| Abstrakt: |
The most recent CDC guidelines for treatment of STDs list a number of syndromes for which ceftriaxone is the recommended therapy, including those caused by N. gonorrhoeae and H. ducreyi. The drug has successfully eradicated incubating syphilis. Its use in primary, secondary, and latent syphilis is promising, although adequate data regarding optimal dose and duration of therapy are not yet available. It remains to be seen whether ceftriaxone represents the sun rising on a new era of successful STD treatment or the sun setting on the old penicillin era. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
